| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |